Showing results (51-60 of 1,512) with videos related to
Sort By:
Pageof 152
Journal of Internal Medicine|February 1, 1990
Haemodilution with medium molecular weight hydroxyethyl starch in patients with peripheral arterial occlusive disease stage IIbH Kiesewetter, J Blume, F Jung, et al.Geburtshilfe Und Frauenheilkunde|June 1, 1992
[Noninvasive function tests in the evaluation of vascular reactivity in pregnancy and pregnancy-induced hypertension]P Ohlmann, F Jung, P Rosenbaum, et al.Infusionstherapie (Basel, Switzerland)|December 1, 1988
[Hemorheologic, micro- and macrocirculatory effects of hypervolemic hemodilution with middle molecular weight hydroxyethyl starch (Haes 200/0.62; 6 percent)]F Jung, P Waldhausen, S Spitzer, et al.Infusionstherapie (Basel, Switzerland)|August 1, 1989
[Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)]F Jung, P Waldhausen, C Mrowietz, et al.Fortschritte Der Medizin|May 17, 1984
[Long-term therapy of angina pectoris. Evaluation of the effectiveness and tolerance of oxyfedrine in ambulatory patients]H Schieffer, N SternitzkeHerz|May 5, 2011
Opportunities and limitations of drug-coated balloons in interventional therapiesB SchellerHerz|October 29, 2014
[Antithrombocytic therapy and PCI. Duration of therapy after DCB/stents/scaffolds]B SchellerClinical Hemorheology and Microcirculation|May 31, 2001
Light and scanning-electron microscopic examination of coronary stents in a perfusion-model. Effects of an NO-donor/quantitative analysisR P Franke, P Reuter, C Mrowietz, et al.Biomedizinische Technik. Biomedical Engineering|September 13, 2001
Haemocompatibility of endovascular coronary stents: Wiktor GXF Jung, R Bach, C Mrowietz, et al.Wiener Medizinische Wochenschrift (1946)|September 15, 1989
[Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease]H Kiesewetter, J Blume, F Jung, et al.Pageof 152